Voltarendiclofenac
According to the FDA label: Use(s) for the temporary relief of arthritis pain ONLY in the following areas head, wrist, elbow (upper body areas) foot, ankle, knee (lower body areas) this product may take up to 7 days to work for arthritis pain; it is not for immediate relief. If no pain relief in 7 days, stop use.
83,775 adverse event reports submitted to the FDA (2001–2026)
Top Reported Adverse Events
The most frequently reported events in association with Voltaren in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.
Show these terms with plain-language definitions
Tap any term below for a plain-language definition.
Drug Ineffective 13,890 reports
A report that the medication did not work as expected for the person taking it. This is a reporting category, not a sign the drug is defective. It simply means someone felt it was not helping their condition.
Full definition in the glossary →Pain 12,479 reports
A general report of physical discomfort, used when no more specific location is given.
Full definition in the glossary →Fatigue 11,525 reports
Extreme tiredness or lack of energy that does not improve with rest.
Full definition in the glossary → See all drugs reporting this event →Rheumatoid Arthritis 9,384 reports
An autoimmune condition where the immune system attacks the joints, causing pain and swelling. It often appears in reports because it is a condition being treated, not always a reaction.
Full definition in the glossary →Rash 8,940 reports
An area of irritated, red, or bumpy skin.
Full definition in the glossary → See all drugs reporting this event →Off Label Use 8,889 reports
Using a medication for a condition or in a way that the FDA has not officially approved. This is common and often legal, and a report of it does not mean something went wrong. Doctors sometimes prescribe drugs off label based on their judgment.
Full definition in the glossary →Arthralgia 8,815 reports
Abdominal Discomfort 8,616 reports
A general unease or mild pain in the belly area.
Full definition in the glossary →Alopecia 8,174 reports
Joint Swelling 7,866 reports
Swelling in or around a joint.
Full definition in the glossary →Systemic Lupus Erythematosus 7,846 reports
An autoimmune condition, often called lupus, where the immune system attacks the body's own tissues, affecting joints, skin, and organs. It often appears in reports because it is a condition being treated, not always a reaction.
Full definition in the glossary →Pemphigus 7,681 reports
A rare autoimmune condition that causes blistering of the skin and the moist linings of the body such as the mouth.
Full definition in the glossary →Glossodynia 7,482 reports
Pain or a burning sensation in the tongue.
Full definition in the glossary →Swelling 7,376 reports
A general report of a body part becoming enlarged, often from fluid or inflammation.
Full definition in the glossary →Arthropathy 7,165 reports
Any disease or disorder of a joint.
Full definition in the glossary →
Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.
Who Is Reporting
Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.
By Sex
View reporter sex data as a table
| Sex | Reports |
|---|---|
| Female | 50,130 |
| Male | 23,394 |
| Unknown | 186 |
By Age Group
View age group data as a table
| Age group | Reports |
|---|---|
| 0-17 | 1,380 |
| 18-34 | 4,473 |
| 35-49 | 14,344 |
| 50-64 | 16,248 |
| 65-74 | 9,677 |
| 75+ | 7,912 |
This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.
Reported Outcomes
Outcomes recorded in FAERS reports that included Voltaren. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.
View outcome data as a table
| Outcome | Reports |
|---|---|
| Other Serious | 49,968 |
| Hospitalization | 30,758 |
| Non-Serious | 16,468 |
| Death | 10,487 |
| Life-Threatening | 9,876 |
| Disability | 9,860 |
Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.
Report Volume Over Time
Number of FAERS reports received per quarter for Voltaren. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.
View report trend as a table
| Year | Reports |
|---|---|
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 725 |
| 2005 | 879 |
| 2006 | 809 |
| 2007 | 957 |
| 2008 | 1,153 |
| 2009 | 1,223 |
| 2010 | 1,513 |
| 2011 | 1,831 |
| 2012 | 1,985 |
| 2013 | 1,784 |
| 2014 | 1,936 |
| 2015 | 2,513 |
| 2016 | 3,437 |
| 2017 | 3,628 |
| 2018 | 6,040 |
| 2019 | 6,404 |
| 2020 | 7,462 |
| 2021 | 7,702 |
| 2022 | 7,185 |
| 2023 | 6,877 |
| 2024 | 8,295 |
| 2025 | 7,990 |
| 2026 (partial) | 1,441 |
The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.
Medications commonly reported with Voltaren
In FDA adverse event reports that mention Voltaren, these medications appeared most often in the same report.
- Diclofenac Topical % (34,390 reports)
- Diclofenac Topical (34,388 reports)
- Methotrexate (20,083 reports)
- Adalimumab (17,548 reports)
- Acetaminophen (17,409 reports)
This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.
Related Drugs
Other medications with similar adverse event profiles in FDA FAERS reports.
Data Source
This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.
View this data on the FDA website →Data last updated: June 2026